Radiation therapy demonstrates a clear survival benefit in the treatment of several
malignancies. However, cancer survivors can develop a wide array of cardiotoxic …

Radiation therapy is an important component of cancer therapy for many malignancies. With
improvements in cardiac-sparing techniques, radiation-induced cardiac dysfunction has …

Background It is unclear whether patients with early-stage Hodgkin's lymphoma and
negative findings on positron-emission tomography (PET) after three cycles of …

Through the success of basic and disease-specific research, cancer survivors are one of the
largest growing subsets of individuals accessing the healthcare system. Interestingly …

Survival rates for most paediatric cancers have improved at a remarkable pace over the past
four decades. In developed countries, cure is now the probable outcome for most children …

Purpose Cardiovascular diseases are increasingly recognized as late effects of Hodgkin
lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Cardiovascular (CV) toxicity is a potential short-or long-term complication of various
anticancer therapies. Some drugs, such as anthracyclines or other biological agents, have …

Adjuvant radiation therapy in the management of early stage breast cancer, Hodgkin's
disease, and to a lesser extent other thoracic malignancies has led to a significant …

Background: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular
heart disease (VHD). We evaluated the determinants of the risk and the radiation dose …